Medicine and the future of health

Reflecting on the past to forge ahead

Dale Fisher, Paul Wicks, Zaheer Ud Din Babar

Research output: Contribution to journalEditorial

1 Citation (Scopus)

Abstract

The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between medical practitioners, pharmaceutical companies, governments and patients. We believe technology and societal expectations will open up the opportunity for more individuals to participate as information becomes more freely available and inequality less acceptable. Corporations must recognize that usual market forces do not function ideally in a setting where health is regarded as a human right, and as modern consumers, patients will increasingly take control of their own data, wellbeing, and even the means of production for developing their own treatments. Ethics and legislation will increasingly impact the processes that facilitate drug development, distribution and administration. This article collection is a cross-journal collaboration, between the Journal of Pharmaceutical Policy and Practice (JoPPP) and BMC Medicine that seeks to cover recent advances in drug development, medicines use, policy and access with high clinical and public health relevance in the future. The Medicine and the Future of Health article collection is a joint collection between BMC Medicine and Journal of Pharmaceutical Policy and Practice. Therefore, this Editorial by the guest editors has been published in both journals.

Original languageEnglish
Article number169
JournalBMC Medicine
Volume14
Issue number1
DOIs
Publication statusPublished - 25 Oct 2016
Externally publishedYes

Fingerprint

Drug and Narcotic Control
Medicine
Health
Pharmaceutical Preparations
Legislation
Ethics
Public Health
Joints
History
Technology
Therapeutics

Cite this

@article{f30d3d8793954f00b5c077caa04b28fc,
title = "Medicine and the future of health: Reflecting on the past to forge ahead",
abstract = "The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between medical practitioners, pharmaceutical companies, governments and patients. We believe technology and societal expectations will open up the opportunity for more individuals to participate as information becomes more freely available and inequality less acceptable. Corporations must recognize that usual market forces do not function ideally in a setting where health is regarded as a human right, and as modern consumers, patients will increasingly take control of their own data, wellbeing, and even the means of production for developing their own treatments. Ethics and legislation will increasingly impact the processes that facilitate drug development, distribution and administration. This article collection is a cross-journal collaboration, between the Journal of Pharmaceutical Policy and Practice (JoPPP) and BMC Medicine that seeks to cover recent advances in drug development, medicines use, policy and access with high clinical and public health relevance in the future. The Medicine and the Future of Health article collection is a joint collection between BMC Medicine and Journal of Pharmaceutical Policy and Practice. Therefore, this Editorial by the guest editors has been published in both journals.",
keywords = "Access, Antibiotics, Corruption, Drug shortages, Drugs, Future, Patient-centred care, Pharmaceuticals, Technology",
author = "Dale Fisher and Paul Wicks and Babar, {Zaheer Ud Din}",
year = "2016",
month = "10",
day = "25",
doi = "10.1186/s12916-016-0717-0",
language = "English",
volume = "14",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central",
number = "1",

}

Medicine and the future of health : Reflecting on the past to forge ahead. / Fisher, Dale; Wicks, Paul; Babar, Zaheer Ud Din.

In: BMC Medicine, Vol. 14, No. 1, 169, 25.10.2016.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Medicine and the future of health

T2 - Reflecting on the past to forge ahead

AU - Fisher, Dale

AU - Wicks, Paul

AU - Babar, Zaheer Ud Din

PY - 2016/10/25

Y1 - 2016/10/25

N2 - The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between medical practitioners, pharmaceutical companies, governments and patients. We believe technology and societal expectations will open up the opportunity for more individuals to participate as information becomes more freely available and inequality less acceptable. Corporations must recognize that usual market forces do not function ideally in a setting where health is regarded as a human right, and as modern consumers, patients will increasingly take control of their own data, wellbeing, and even the means of production for developing their own treatments. Ethics and legislation will increasingly impact the processes that facilitate drug development, distribution and administration. This article collection is a cross-journal collaboration, between the Journal of Pharmaceutical Policy and Practice (JoPPP) and BMC Medicine that seeks to cover recent advances in drug development, medicines use, policy and access with high clinical and public health relevance in the future. The Medicine and the Future of Health article collection is a joint collection between BMC Medicine and Journal of Pharmaceutical Policy and Practice. Therefore, this Editorial by the guest editors has been published in both journals.

AB - The development of new therapies has a rich history, evolves quickly with societal trends, and will have an exciting future. The last century has seen an exponential increase in complex interactions between medical practitioners, pharmaceutical companies, governments and patients. We believe technology and societal expectations will open up the opportunity for more individuals to participate as information becomes more freely available and inequality less acceptable. Corporations must recognize that usual market forces do not function ideally in a setting where health is regarded as a human right, and as modern consumers, patients will increasingly take control of their own data, wellbeing, and even the means of production for developing their own treatments. Ethics and legislation will increasingly impact the processes that facilitate drug development, distribution and administration. This article collection is a cross-journal collaboration, between the Journal of Pharmaceutical Policy and Practice (JoPPP) and BMC Medicine that seeks to cover recent advances in drug development, medicines use, policy and access with high clinical and public health relevance in the future. The Medicine and the Future of Health article collection is a joint collection between BMC Medicine and Journal of Pharmaceutical Policy and Practice. Therefore, this Editorial by the guest editors has been published in both journals.

KW - Access

KW - Antibiotics

KW - Corruption

KW - Drug shortages

KW - Drugs

KW - Future

KW - Patient-centred care

KW - Pharmaceuticals

KW - Technology

UR - http://www.scopus.com/inward/record.url?scp=84992365457&partnerID=8YFLogxK

U2 - 10.1186/s12916-016-0717-0

DO - 10.1186/s12916-016-0717-0

M3 - Editorial

VL - 14

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

M1 - 169

ER -